Investor Relations
Key Figures
| IFRS (in EURm except otherwise stated) | 2018 | 2017 |
| Revenues | 3,781.1 | 2,971.4 |
| Adjusted EBITDA | 719.8 | 556.7 |
| Reported EBITDA | 651.4 | 513.2 |
| Adjusted Basic EPS (EUR) | 20.11 | 17.49 |
| Net Operating Cash Flow | 543.9 | 405.1 |
Outstanding shares:
17,851,946 (at 31.10.2019)
Dividend
The AGM of 25 April 2019 approved the payment of a dividend of EUR 2.88 per share for the year 2018 compared to EUR 2.40 for the previous year.
Financial News
- 28.10.2019Eurofins reports strong organic growth (over 6%) in Q3 2019
- 17.10.2019Eurofins completes its hybrid capital refinancing exercise finalising its new mid-term financing structure
- 11.10.2019Transplant Genomics, Inc. Confirms TruGraf Will Receive Medicare Coverage Effective November 25, 2019
- 11.09.2019Eurofins announces the success of its Tender Offer on its 300M€ outstanding hybrid notes with a first call date on 31 January 2020
- 04.09.2019Eurofins successfully prices EUR 300m new hybrid notes
Annual Reports
Next Publication: FY 2019 Results Publication, 4 March 2020 (TBC)
Sign up to Eurofins' IR distribution list
Eurofins' 20-year IPO value creation study by Marten & Co.
Research Paper by Prof. Brooks
OBSAAR prospectus in French only